Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,537 | 329 | 99.5% |
| Education | $26.81 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $896.95 | 47 | $0 (2024) |
| Novo Nordisk Inc | $793.69 | 58 | $0 (2024) |
| Abbott Laboratories | $713.05 | 43 | $0 (2024) |
| Insulet Corporation | $348.13 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $321.09 | 21 | $0 (2024) |
| Esperion Therapeutics, Inc. | $284.19 | 19 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $193.42 | 10 | $0 (2022) |
| Tandem Diabetes Care, Inc. | $185.87 | 7 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $181.00 | 11 | $0 (2022) |
| Mannkind Corporation | $152.25 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,127 | 62 | Novo Nordisk Inc ($207.76) |
| 2023 | $1,322 | 74 | Lilly USA, LLC ($392.18) |
| 2022 | $1,709 | 108 | Lilly USA, LLC ($295.41) |
| 2021 | $1,405 | 88 | Abbott Laboratories ($228.92) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.49 | General |
| Category: Insulin Pump | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: Insulin Pump | ||||||
| 11/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: ENDOCRINE AGENT | ||||||
| 10/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: Endocrinology | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.74 | General |
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Endocrinology | ||||||
| 08/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: Insulin Pump | ||||||
| 08/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 260 | 497 | $106,274 | $29,165 |
| 2022 | 10 | 557 | 810 | $112,251 | $29,088 |
| 2021 | 13 | 753 | 1,089 | $113,539 | $29,541 |
| 2020 | 15 | 757 | 989 | $64,005 | $20,770 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 355 | $90,170 | $25,604 | 28.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 72 | 128 | $13,696 | $2,771 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $2,408 | $790.14 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 310 | $78,740 | $21,582 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 16 | $5,488 | $1,765 | 32.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 97 | 135 | $3,375 | $1,393 | 41.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 97 | 127 | $10,160 | $1,213 | 11.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 58 | 65 | $2,925 | $1,056 | 36.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 30 | 47 | $5,029 | $996.86 | 19.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 40 | 43 | $4,214 | $548.52 | 13.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 18 | 19 | $760.00 | $272.98 | 35.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 24 | 24 | $360.00 | $137.46 | 38.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 24 | 24 | $1,200 | $123.27 | 10.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 160 | 271 | $68,834 | $20,005 | 29.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 124 | 203 | $5,075 | $2,088 | 41.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 120 | 198 | $15,840 | $1,885 | 11.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 78 | 103 | $4,635 | $1,702 | 36.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 64 | 69 | $6,762 | $923.91 | 13.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 22 | 35 | $3,745 | $787.78 | 21.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $1,892 | $527.22 | 27.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 24 | 30 | $1,200 | $442.38 | 36.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2021 | 54 | 60 | $900.00 | $337.18 | 37.5% |
| 84681 | C-peptide (protein) level | Office | 2021 | 16 | 16 | $816.00 | $332.96 | 40.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 53 | 59 | $2,950 | $297.00 | 10.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 15 | 20 | $400.00 | $169.20 | 42.3% |
About Amy Baird, ARNP
Amy Baird, ARNP is a Adult Health healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073697546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Baird, ARNP has received a total of $5,564 in payments from pharmaceutical and medical device companies, with $1,127 received in 2024. These payments were reported across 332 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,537).
As a Medicare-enrolled provider, Baird has provided services to 2,327 Medicare beneficiaries, totaling 3,385 services with total Medicare billing of $108,564. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Other Specialties Nurse Practitioner
- Location Louisville, KY
- Active Since 10/24/2006
- Last Updated 01/23/2019
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1073697546
Products in Payments
- FREESTYLE LIBRE (Device) $484.13
- TRULICITY (Drug) $464.91
- Omnipod (Device) $348.13
- Rybelsus (Drug) $316.82
- Ozempic (Drug) $284.61
- NEXLETOL (Drug) $284.19
- JARDIANCE (Drug) $245.42
- HUMULIN (Drug) $213.54
- FreeStyle Libre (Device) $204.60
- FARXIGA (Drug) $176.58
- AFREZZA (Drug) $152.25
- ISTURISA (Drug) $137.39
- TRADJENTA (Drug) $134.25
- Repatha (Biological) $123.02
- t:slim X2 Insulin Pump with Control-IQ (Device) $122.32
- STRENSIQ (Biological) $107.44
- TOUJEO (Biological) $102.84
- Kerendia (Drug) $100.78
- Wegovy (Drug) $99.01
- Korlym (Drug) $88.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Louisville
Miss. Kimberly Vessels, Np-C, NP-C
Adult Health — Payments: $56,907
Ms. Heidi Gallo, Arnp, ARNP
Adult Health — Payments: $14,488
Karen Eastridge, Np-C, Cde, NP-C, CDE
Adult Health — Payments: $9,689
Mistie Teer, Aprn, APRN
Adult Health — Payments: $7,748
Amanda Jones, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Adult Health — Payments: $3,428
Layla Al-Shami, Arnp, ARNP
Adult Health — Payments: $3,061